Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Public offering nets $138mm for Veracyte

Executive Summary

Veracyte Inc. (genomic testing) netted $138mm through a public offering of 6.3mm common shares (including the overallotment) at $23.25. The company will use some of the proceeds to repay $12.4mm on an outstanding loan and will put the rest of the funds towards corporate needs, including potential strategic investments or acquisitions.
Deal Industry
  • In Vitro Diagnostics
    • Cytology
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies